These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8218941)

  • 1. Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy.
    Olsson I; Gatanaga T; Gullberg U; Lantz M; Granger GA
    Eur Cytokine Netw; 1993; 4(3):169-80. PubMed ID: 8218941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
    Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
    Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of an Asn/Val cleavage site in the production of a soluble form of a human tumor necrosis factor (TNF) receptor. Site-directed mutagenesis of a putative cleavage site in the p55 TNF receptor chain.
    Gullberg U; Lantz M; Lindvall L; Olsson I; Himmler A
    Eur J Cell Biol; 1992 Aug; 58(2):307-12. PubMed ID: 1330568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells.
    Gallea-Robache S; Morand V; Millet S; Bruneau JM; Bhatnagar N; Chouaib S; Roman-Roman S
    Cytokine; 1997 May; 9(5):340-6. PubMed ID: 9195133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB
    J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of expression of transmembrane and soluble 75 kDa tumor necrosis factor receptors by interferon-gamma and granulocyte-macrophage colony-stimulating factor involves transcriptional activation.
    Mylius-Spencker H; Winzen R; Resch K; Holtmann H
    Eur Cytokine Netw; 1997 Dec; 8(4):351-8. PubMed ID: 9459614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities--the role of bupropion.
    Kast RE
    Leuk Res; 2005 Dec; 29(12):1459-63. PubMed ID: 15964626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
    Rasmussen CA; Pace JL; Banerjee S; Phillips TA; Hunt JS
    Placenta; 1999; 20(2-3):213-22. PubMed ID: 10195744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of porcine recombinant soluble tumor necrosis factor receptor 1.
    Maroushek Boury N; Bosworth BT; Stabel TJ; Kehrli ME; Taylor MJ
    Am J Vet Res; 1998 Oct; 59(10):1317-22. PubMed ID: 9781468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells.
    Choi SS; Gatanaga M; Granger GA; Gatanaga T
    Cell Immunol; 1996 Jun; 170(2):178-84. PubMed ID: 8660816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
    Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
    Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimerization of chimeric erythropoietin/75 kDa tumour necrosis factor (TNF) receptors transduces TNF signals: necessity for the 75 kDa-TNF receptor transmembrane domain.
    Declercq W; Vandenabeele P; Fiers W
    Cytokine; 1995 Oct; 7(7):701-9. PubMed ID: 8580379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
    Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR; Dawes PT; Nixon NB; Mattey DL
    Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases.
    Xanthoulea S; Pasparakis M; Kousteni S; Brakebusch C; Wallach D; Bauer J; Lassmann H; Kollias G
    J Exp Med; 2004 Aug; 200(3):367-76. PubMed ID: 15289505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation.
    Vielhauer V; Mayadas TN
    Semin Nephrol; 2007 May; 27(3):286-308. PubMed ID: 17533007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.
    Aderka D; Sorkine P; Abu-Abid S; Lev D; Setton A; Cope AP; Wallach D; Klausner J
    J Clin Invest; 1998 Feb; 101(3):650-9. PubMed ID: 9449699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of TNF-alpha binding peptides from a D-amino acid hexapeptide library that specifically inhibit TNF-alpha binding to recombinant p55 receptor.
    Kruszynski M; Shealy DJ; Leone AO; Heavner GA
    Cytokine; 1999 Jan; 11(1):37-44. PubMed ID: 10080877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.